Literature DB >> 18276145

4-Biphenyl and 2-naphthyl substituted 6,7-dimethoxytetrahydroisoquinoline derivatives as potent P-gp modulators.

Nicola Antonio Colabufo1, Francesco Berardi, Mariangela Cantore, Maria Grazia Perrone, Marialessandra Contino, Carmela Inglese, Mauro Niso, Roberto Perrone, Amalia Azzariti, Grazia Maria Simone, Angelo Paradiso.   

Abstract

Starting from lead compound 1 (EC(50)=1.64 microM), its non-basic nucleus has been conformationally restricted by 4-biphenyl and 2-naphthyl moieties. In each series we investigated if the presence of H-bond donor or acceptor substituents, the basicity and the lipophilicity (clogP) were correlated with the P-gp inhibiting activity of tested compounds. In the biphenyl series, derivative 4d displayed the best results (EC(50)=0.05 microM). The corresponding amide 3d was found less active (EC(50)=3.5 microM) ascertaining the importance of basicity in this series whilst the presence of hydroxy or methoxy substituents seems to be negligible. In the naphthyl series, both the basicity and the presence of H-bond donor or acceptor groups seem to be negligible. Moreover, the lipophilicity did not influence the P-gp inhibition activity of each series. Specific biological assays have been carried out to establish the P-gp interacting mechanism of tested compounds discriminating between substrates and inhibitors. Moreover, compound 4d displayed a potent P-gp inhibition activity with good selectivity towards BCRP pump.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18276145     DOI: 10.1016/j.bmc.2008.01.055

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  7 in total

1.  Synthesis and preclinical evaluation of the radiolabeled P-glycoprotein inhibitor [(11)C]MC113.

Authors:  Severin Mairinger; Thomas Wanek; Claudia Kuntner; Yaprak Doenmez; Sabine Strommer; Johann Stanek; Elena Capparelli; Peter Chiba; Markus Müller; Nicola A Colabufo; Oliver Langer
Journal:  Nucl Med Biol       Date:  2012-09-13       Impact factor: 2.408

2.  New tetrahydroisoquinoline-based P-glycoprotein modulators: decoration of the biphenyl core gives selective ligands.

Authors:  Marialessandra Contino; Stefano Guglielmo; Maria Grazia Perrone; Roberta Giampietro; Barbara Rolando; Antonio Carrieri; Daniele Zaccaria; Konstantin Chegaev; Vanessa Borio; Chiara Riganti; Katarzyna Zabielska-Koczywąs; Nicola A Colabufo; Roberta Fruttero
Journal:  Medchemcomm       Date:  2018-04-03       Impact factor: 3.597

3.  HZ08 reverse P-glycoprotein mediated multidrug resistance in vitro and in vivo.

Authors:  Zheyi Hu; Zaigang Zhou; Yahui Hu; Jinhui Wu; Yunman Li; Wenlong Huang
Journal:  PLoS One       Date:  2015-02-17       Impact factor: 3.240

Review 4.  Small and Innovative Molecules as New Strategy to Revert MDR.

Authors:  Laura Zinzi; Elena Capparelli; Mariangela Cantore; Marialessandra Contino; Marcello Leopoldo; Nicola Antonio Colabufo
Journal:  Front Oncol       Date:  2014-01-21       Impact factor: 6.244

Review 5.  ABC transporters in CSCs membranes as a novel target for treating tumor relapse.

Authors:  Laura Zinzi; Marialessandra Contino; Mariangela Cantore; Elena Capparelli; Marcello Leopoldo; Nicola A Colabufo
Journal:  Front Pharmacol       Date:  2014-07-10       Impact factor: 5.810

6.  Crystallographic study of PET radio-tracers in clinical evaluation for early diagnosis of Alzheimers.

Authors:  Angela Altomare; Elena Capparelli; Antonio Carrieri; Nicola A Colabufo; Anna Moliterni; Rosanna Rizzi; Dritan Siliqi
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-10-04

7.  New Tetrahydroisoquinoline Derivatives Overcome Pgp Activity in Brain-Blood Barrier and Glioblastoma Multiforme in Vitro.

Authors:  Iris Chiara Salaroglio; Elena Gazzano; Joanna Kopecka; Konstantin Chegaev; Costanzo Costamagna; Roberta Fruttero; Stefano Guglielmo; Chiara Riganti
Journal:  Molecules       Date:  2018-06-09       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.